Impact of different antibiotics on methane production using waste-activated sludge: mechanisms and microbial community dynamics

Nurul Asyifah Mustapha, Kenji Sakai, Yoshihito Shirai, Toshinari Maeda

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Anaerobic digestion is an effective method for reducing the by-product of waste-activated sludge (WAS) from wastewater treatment plants and for producing bioenergy from WAS. However, only a limited number of studies have attempted to improve anaerobic digestion by targeting the microbial interactions in WAS. In this study, we examined whether different antibiotics positively, negatively, or neutrally influence methane fermentation by evaluating changes in the microbial community and functions in WAS. Addition of azithromycin promoted the microbial communities related to the acidogenic and acetogenic stages, and a high concentration of soluble proteins and a high activity of methanogens were detected. Chloramphenicol inhibited methane production but did not affect the bacteria that contribute to the hydrolysis, acidogenesis, and acetogenesis digestion stages. The addition of kanamycin, which exhibits the same methane productivity as a control (antibiotic-free WAS), did not affect all of the microbial communities during anaerobic digestion. This study demonstrates the simultaneous functions and interactions of diverse bacteria and methanogenic Archaea in different stages of the anaerobic digestion of WAS. The ratio of Caldilinea, Methanosarcina, and Clostridium may correspond closely to the trend of methane production in each antibiotic. The changes in microbial activities and function by antibiotics facilitate a better understanding of bioenergy production.

Original languageEnglish
Pages (from-to)9355-9364
Number of pages10
JournalApplied Microbiology and Biotechnology
Volume100
Issue number21
DOIs
Publication statusPublished - Nov 1 2016

Fingerprint

Methane
Sewage
Digestion
Anti-Bacterial Agents
Methanosarcina
Microbial Interactions
Waste Products
Bacteria
Azithromycin
Kanamycin
Clostridium
Archaea
Chloramphenicol
Waste Water
Fermentation
Hydrolysis
Proteins

All Science Journal Classification (ASJC) codes

  • Biotechnology
  • Applied Microbiology and Biotechnology

Cite this

Impact of different antibiotics on methane production using waste-activated sludge : mechanisms and microbial community dynamics. / Mustapha, Nurul Asyifah; Sakai, Kenji; Shirai, Yoshihito; Maeda, Toshinari.

In: Applied Microbiology and Biotechnology, Vol. 100, No. 21, 01.11.2016, p. 9355-9364.

Research output: Contribution to journalArticle

@article{b3e92f58ec5d46a79930b0d8d7275ad0,
title = "Impact of different antibiotics on methane production using waste-activated sludge: mechanisms and microbial community dynamics",
abstract = "Anaerobic digestion is an effective method for reducing the by-product of waste-activated sludge (WAS) from wastewater treatment plants and for producing bioenergy from WAS. However, only a limited number of studies have attempted to improve anaerobic digestion by targeting the microbial interactions in WAS. In this study, we examined whether different antibiotics positively, negatively, or neutrally influence methane fermentation by evaluating changes in the microbial community and functions in WAS. Addition of azithromycin promoted the microbial communities related to the acidogenic and acetogenic stages, and a high concentration of soluble proteins and a high activity of methanogens were detected. Chloramphenicol inhibited methane production but did not affect the bacteria that contribute to the hydrolysis, acidogenesis, and acetogenesis digestion stages. The addition of kanamycin, which exhibits the same methane productivity as a control (antibiotic-free WAS), did not affect all of the microbial communities during anaerobic digestion. This study demonstrates the simultaneous functions and interactions of diverse bacteria and methanogenic Archaea in different stages of the anaerobic digestion of WAS. The ratio of Caldilinea, Methanosarcina, and Clostridium may correspond closely to the trend of methane production in each antibiotic. The changes in microbial activities and function by antibiotics facilitate a better understanding of bioenergy production.",
author = "Mustapha, {Nurul Asyifah} and Kenji Sakai and Yoshihito Shirai and Toshinari Maeda",
year = "2016",
month = "11",
day = "1",
doi = "10.1007/s00253-016-7767-2",
language = "English",
volume = "100",
pages = "9355--9364",
journal = "Applied Microbiology and Biotechnology",
issn = "0175-7598",
publisher = "Springer Verlag",
number = "21",

}

TY - JOUR

T1 - Impact of different antibiotics on methane production using waste-activated sludge

T2 - mechanisms and microbial community dynamics

AU - Mustapha, Nurul Asyifah

AU - Sakai, Kenji

AU - Shirai, Yoshihito

AU - Maeda, Toshinari

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Anaerobic digestion is an effective method for reducing the by-product of waste-activated sludge (WAS) from wastewater treatment plants and for producing bioenergy from WAS. However, only a limited number of studies have attempted to improve anaerobic digestion by targeting the microbial interactions in WAS. In this study, we examined whether different antibiotics positively, negatively, or neutrally influence methane fermentation by evaluating changes in the microbial community and functions in WAS. Addition of azithromycin promoted the microbial communities related to the acidogenic and acetogenic stages, and a high concentration of soluble proteins and a high activity of methanogens were detected. Chloramphenicol inhibited methane production but did not affect the bacteria that contribute to the hydrolysis, acidogenesis, and acetogenesis digestion stages. The addition of kanamycin, which exhibits the same methane productivity as a control (antibiotic-free WAS), did not affect all of the microbial communities during anaerobic digestion. This study demonstrates the simultaneous functions and interactions of diverse bacteria and methanogenic Archaea in different stages of the anaerobic digestion of WAS. The ratio of Caldilinea, Methanosarcina, and Clostridium may correspond closely to the trend of methane production in each antibiotic. The changes in microbial activities and function by antibiotics facilitate a better understanding of bioenergy production.

AB - Anaerobic digestion is an effective method for reducing the by-product of waste-activated sludge (WAS) from wastewater treatment plants and for producing bioenergy from WAS. However, only a limited number of studies have attempted to improve anaerobic digestion by targeting the microbial interactions in WAS. In this study, we examined whether different antibiotics positively, negatively, or neutrally influence methane fermentation by evaluating changes in the microbial community and functions in WAS. Addition of azithromycin promoted the microbial communities related to the acidogenic and acetogenic stages, and a high concentration of soluble proteins and a high activity of methanogens were detected. Chloramphenicol inhibited methane production but did not affect the bacteria that contribute to the hydrolysis, acidogenesis, and acetogenesis digestion stages. The addition of kanamycin, which exhibits the same methane productivity as a control (antibiotic-free WAS), did not affect all of the microbial communities during anaerobic digestion. This study demonstrates the simultaneous functions and interactions of diverse bacteria and methanogenic Archaea in different stages of the anaerobic digestion of WAS. The ratio of Caldilinea, Methanosarcina, and Clostridium may correspond closely to the trend of methane production in each antibiotic. The changes in microbial activities and function by antibiotics facilitate a better understanding of bioenergy production.

UR - http://www.scopus.com/inward/record.url?scp=84982162427&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84982162427&partnerID=8YFLogxK

U2 - 10.1007/s00253-016-7767-2

DO - 10.1007/s00253-016-7767-2

M3 - Article

C2 - 27531514

AN - SCOPUS:84982162427

VL - 100

SP - 9355

EP - 9364

JO - Applied Microbiology and Biotechnology

JF - Applied Microbiology and Biotechnology

SN - 0175-7598

IS - 21

ER -